Control of the Functional Activity of an Antisense RNA by a Tetracycline-Responsive Derivative of the Human U6 snRNA Promoter
- 1 March 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 11 (4), 577-585
- https://doi.org/10.1089/10430340050015761
Abstract
In an effort to develop a regulatable derivative of the promoter of the human gene for U6 snRNA, we generated several constructs composed of the human U6 snRNA promoter and sequences derived from the gene for the tetracycline operator of a prokaryotic tetracycline resistance transposon. One of the constructs had strong transcriptional activity in the presence of tetracycline that was equivalent to 80% of the activity of the wild-type promoter. Furthermore, the transcriptional activity was almost completely repressed in the absence of tetracycline. Transcriptional activity became detectable within 4 hr after the addition of tetracycline to the culture medium. We used this system to control the functional activity of an antisense RNA for a chimeric gene derived from genes for the epidermal growth factor receptor (EGFR) and green fluorescent protein (GFP). A plasmid that expressed the chimeric gene and a plasmid that expressed the antisense RNA under the control of the inducible U6 promoter were used to cotransfect HeLa cells that were producing the tetracycline repressor protein (Tet R). Addition of tetracycline to the culture medium 12 hr after transfection resulted in the almost complete disappearance of the fluorescent signal due to the chimeric protein within 24 hr. Our results suggest that this expression system might be a useful tool for controlling the expression of functional RNAs, such as aptamers and antisense RNAs, both in basic research and in gene therapy.Keywords
This publication has 38 references indexed in Scilit:
- Formation of a catalytically active dimer by tRNAVal -driven short ribozymesNature Biotechnology, 1998
- Efficient Ex Vivo Inhibition of Perforin and Fas Ligand Expression by Chimeric tRNA–Hammerhead RibozymesHuman Gene Therapy, 1998
- Expression of small, therapeutic RNAs in human cell nucleiGene Therapy, 1997
- Repression of Vertebrate RNA Polymerase III Transcription by DNA Binding Proteins Located Upstream from the Transcription Start SiteJournal of Molecular Biology, 1995
- Targeting TBP to a non-TATA box cis-regulatory element: a TBP-containing complex activates transcription from snRNA promoters through the PSE.Genes & Development, 1993
- S. cerevisiae TFIIIB is the transcription initiation factor proper of RNA polymerase III, while TFIIIA and TFIIIC are assembly factorsCell, 1990
- Changing the RNA polymerase specificity of U snRNA gene promotersCell, 1988
- A heat-shock-inducible eukaryotic expression vectoGene, 1988
- Control of expression of the Tn10-encoded tetracycline resistance operon II. Interaction of RNA polymerase and TET repressor with the tet operon regulatory regionJournal of Molecular Biology, 1984
- Small molecular weight monodisperse nuclear RNAJournal of Molecular Biology, 1968